Preclinical trial of avocado pulp supplementation in an L-NAME model of cardiovascular injury
Journal of Dietitians Association of Nigeria · 2026 · 17 (1) · 1-12
DOI: 10.4314/jdan.v17i1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dietitians Association of Nigeria, 2026. Verfasst von Joy A.C. Amadi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endothelial dysfunction, dyslipidemia, and myocardial injury are major contributors to cardiovascular disease. Avocado (Persea americana), rich in monounsaturated fatty acids and phytochemicals, has shown lipid-lowering and anti-inflammatory properties, but its integrated effects on vascular injury remain unclear.
Objectives
The study evaluated the proof-of-concept evidence on the effect of avocado pulp supplementation on multi-system pathological phenotype (metabolic dysfunction, dyslipidemia, myocardial stress and vascular activation) in an L-NAME rat model of cardiovascular injury.
Methods
Male rats were randomized into six groups (n = 4 per group): control (normal chow, water only), avocado (normal chow + avocado + water only), L-NAME, L-NAME+drugs (metoprolol+losartan), L-NAME+avocado, and L-NAME+drugs+avocado (Groups 1 to 6, respectively). Morphometric indices, lipid profiles, cardiac injury enzymes, and vascular biomarkers were measured after treatment. One-way ANOVA with Tukey’s test assessed group differences, while contour plots and correlation networks visualized biomarker interactions.
Results
L-NAME treatment to groups 3 to 6 induced a pathological phenotype characterized by reduced feed efficiency (–40%), weight gain (–80%), and BMI (–18%), together with dyslipidemia (LDL +120%, TG +55%, TC +42%, HDL –28%), myocardial stress (troponin +70%, CK +50%, LDH +35%), and vascular activation (endothelin +350%, VCAM-1 +55%, AngII +80%; all p < 0.01). Avocado supplementation mitigated these effects: BMI and feed efficiency returned to near-control levels, LDL, TG, and TC fell by 30–45%, and troponin, CK, and LDH decreased by ~25–30%. Endothelin, VCAM-1, and AngII were reduced by 40–55% relative to L-NAME. Network analysis revealed dense pathological correlations under L-NAME (density 0.42), simplified under avocado (0.17), and most normalized with avocado+drugs (0.09), indicating restoration of physiological biomarker independence.
Conclusion
Avocado supplementation attenuates L-NAME–induced vascular injury by improving metabolic efficiency, correcting dyslipidemia, reducing cardiac injury, and dampening endothelial activation, while proposing a potential capacity to shift the pathological biomarker network towards a more control-like organization in such a preclinical proof-of-concept- study.
Zitieren
APA
Amadi, J. A., Aloy-Amadi, O. A., & Chukwu, C. H. (2026). Preclinical trial of avocado pulp supplementation in an L-NAME model of cardiovascular injury. Journal of Dietitians Association of Nigeria, 17(1), 1-12. https://doi.org/10.4314/jdan.v17i1.1
Vancouver
Amadi JA, Aloy-Amadi OA, Chukwu CH. Preclinical trial of avocado pulp supplementation in an L-NAME model of cardiovascular injury. Journal of Dietitians Association of Nigeria. 2026;17(1):1-12. doi:10.4314/jdan.v17i1.1
BibTeX
@article{Amadi2026,
author = {Amadi, Joy A.C. and Aloy-Amadi, Oluchi A. and Chukwu, Chukwuma H.},
title = {Preclinical trial of avocado pulp supplementation in an L-NAME model of cardiovascular injury},
journal = {Journal of Dietitians Association of Nigeria},
year = {2026},
volume = {17},
number = {1},
pages = {1--12},
doi = {10.4314/jdan.v17i1.1}
}
EUVIMED